A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia

Background. Ceftobiprole, the active moiety of ceftobiprole medocaril, is a novel broad-spectrum cephalosporin, with bactericidal activity against a wide range of gram-positive bacteria, including Staphylococcus aureus (including methicillin-resistant strains) and penicillin- and ceftriaxone-resista...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Awad, Samir S., Rodriguez, Alejandro H., Chuang, Yin-Ching, Marjanek, Zsuszanna, Pareigis, Alex J., Reis, Gilmar, Scheeren, Thomas W. L., Sánchez, Alejandro S., Zhou, Xin, Saulay, Mikaël, Engelhardt, Marc
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305133/
https://ncbi.nlm.nih.gov/pubmed/24723282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu219
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados